Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank97
Year-over-Year Change
Year-over-year revenue growth rate
Latest
840.86%
↑ 367% vs avg
Percentile
P97
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
179.95%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 840.86% |
| Q2 2025 | 14.81% |
| Q1 2025 | -95.51% |
| Q4 2024 | 830.93% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | -100.00% |
| Q2 2022 | -56.96% |
| Q1 2022 | 33.40% |
| Q4 2021 | 53.16% |
| Q3 2021 | -88.40% |
| Q2 2021 | 4738.71% |
| Q1 2021 | -53.38% |
| Q4 2020 | -66.75% |
| Q3 2020 | -46.60% |
| Q2 2020 | -26.13% |
| Q1 2020 | -31.53% |
| Q4 2019 | 5.94% |
| Q3 2019 | -14.13% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |